Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

Neogap Therapeutics, a Swedish clinical-stage biotechnology company, has entered a strategic collaboration with NorthX Biologics, a leading CDMO, to advance manufacturing

READ MORE

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

Shanghai, China & JERSEY CITY, N.J., United States:   Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the

READ MORE